Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

523 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: results from the RAPID 1 randomized controlled trial.
Strand V, Mease P, Burmester GR, Nikaï E, Coteur G, van Vollenhoven R, Combe B, Keystone EC, Kavanaugh A. Strand V, et al. Arthritis Res Ther. 2009;11(6):R170. doi: 10.1186/ar2859. Epub 2009 Nov 12. Arthritis Res Ther. 2009. PMID: 19909548 Free PMC article. Clinical Trial.
Biologic agents in autoimmune diseases.
Keystone EC, Strand V. Keystone EC, et al. Among authors: strand v. J Rheumatol. 1996 Apr;23(4):743-6. J Rheumatol. 1996. PMID: 8730137 No abstract available.
Biologic agents for the treatment of rheumatoid arthritis.
Strand V, Keystone E, Breedveld F. Strand V, et al. Rheum Dis Clin North Am. 1996 Feb;22(1):117-32. doi: 10.1016/s0889-857x(05)70265-9. Rheum Dis Clin North Am. 1996. PMID: 8907068 Free article. Review.
Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.
Strand V, Tugwell P, Bombardier C, Maetzel A, Crawford B, Dorrier C, Thompson A, Wells G. Strand V, et al. Arthritis Rheum. 1999 Sep;42(9):1870-8. doi: 10.1002/1529-0131(199909)42:9<1870::AID-ANR11>3.0.CO;2-D. Arthritis Rheum. 1999. PMID: 10513801 Free article. Clinical Trial.
Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Leflunomide Rheumatoid Arthritis Investigators Group.
Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G, Fox R, Moreland L, Olsen N, Furst D, Caldwell J, Kaine J, Sharp J, Hurley F, Loew-Friedrich I. Strand V, et al. Arch Intern Med. 1999 Nov 22;159(21):2542-50. doi: 10.1001/archinte.159.21.2542. Arch Intern Med. 1999. PMID: 10573044 Clinical Trial.
Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.
Tugwell P, Wells G, Strand V, Maetzel A, Bombardier C, Crawford B, Dorrier C, Thompson A. Tugwell P, et al. Among authors: strand v. Arthritis Rheum. 2000 Mar;43(3):506-14. doi: 10.1002/1529-0131(200003)43:3<506::AID-ANR5>3.0.CO;2-U. Arthritis Rheum. 2000. PMID: 10728742 Free article. Clinical Trial.
Biologic agents in the treatment of rheumatoid arthritis.
Haraoui B, Strand V, Keystone E. Haraoui B, et al. Among authors: strand v. Curr Pharm Biotechnol. 2000 Nov;1(3):217-33. doi: 10.2174/1389201003378915. Curr Pharm Biotechnol. 2000. PMID: 11469381 Review.
523 results